China boosts Gulf ties with UAE vaccine deal
Joint venture between Sinopharm and G42 aims to produce up to 200-million doses annually
29 March 2021 - 09:00
China is partnering with the United Arab Emirates to make millions of doses of its state-backed Sinopharm vaccine, in a deal that takes manufacturing of the shot overseas for the first time and deepens Beijing’s influence in the Middle East.
A newly created joint venture between Sinopharm and Abu Dhabi-based G42 aims to produce up to 200-million doses annually at a plant that will become operational this year, the companies said...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.